Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Fondaparinux sodium is a factor Xa inhibitor that mediates the interaction of herparin with antithrombins. It is used for the prevention of venous thromboembolism after surgery. Synonyms: Arixtra; Quixidar; Fondaparinux sodium salt; PENTA; Arixtra; Xantidar; SR 90107A; IC-85158; SR-90107A; SR90107A; IC 85158; IC85158; α-D-Glucopyranoside, methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(1→4)-O-β-D-glucopyranuronosyl-(1→4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(1→4)-O-2-O-sulfo-α-L-idopyranuronosyl-(1→4)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate), sodium salt (1:10); Fondaparin; Fondaparin sodium; Fondaparinux; IC 851589; Org 31540. Grade: >95%. CAS No. 114870-03-0. Molecular formula: C31H43N3Na10O49S8. Mole weight: 1728.08.
Fondaparinux sodium for Assay
United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards.
Fondaparinux sodium identification
United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards.
Fondaparinux Sodium Impurity
Fondaparinux Sodium Impurity is derived from Heparin Sodium Salt, which is a heterogeneous mixture of variably sulfated polysaccharide chains. It acts as an anti-congulant, due to various anti-thrombin binding sites along the molecular structure. Synonyms: Methyl 2-Deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-α-D-glucopyranoside 6-(Hydrogen Sulfate) Sodium Salt (1:4). CAS No. 1809833-99-5. Molecular formula: C13H17NNa4O19S3. Mole weight: 679.42.
Fondaparinux sodium impurity 1
Fondaparinux sodium impurity 1 is an impurity of fondaparinux sodium primarily utilized for the prevention and therapy of deep vein thrombosis (DVT) and pulmonary embolism (PE). Synonyms: UNII-3S9ZQK69SK3S9ZQK69SK; 348625-84-3; (2R,3R,4S)-4-hydroxy-2-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl]oxy-3-sulfooxy-3,4-dihydro-2H-pyran-6-carboxylic acidalpha-D-Glucopyranoside, methyl 2-deoxy-4-O-(4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-, 6-(hydrogen sulfate). Grade: > 95%. CAS No. 348625-84-3. Molecular formula: C13H17NO19S3Na4. Mole weight: 679.43.
Fondaparinux sodium System Suitability Mixture A
United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards.
Fondaparinux sodium System Suitability Mixture B
United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards.
Fondaparinux-13C6 Sodium
Isotope labelled Fondaparinux, a synthetic pentasaccharide corresponding to the anti-thrombin binding site of heparin. Anti-thrombotic. Synonyms: Methyl O-2-Deoxy-6-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(14)-O-β-D-glucopyranuronosyl-(14)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-α-D-glucopyranosyl-(14)-O-2-O-sulfo-α-L-idopyranuronosyl-(14)-2-deoxy-2-(sulfoamino)-α-D-glucopyranoside 6-(Hydrogen Sulfate) Decasodium Salt-13C6; Arixtra-13C6; Fondaparin Sodium-13C6; IC 85158-13C6; IC 851589-13C6; Org 31540-13C6; SR 90107A-13C6; Xantidar-13C6. Molecular formula: C25[13C]6H43N3Na10O49S8. Mole weight: 1734.1.